Related Experiment Video
Updated: May 1, 2026
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
Published on: September 25, 2012
Non-germinomatous germ cell tumors of the CNS: Classification, diagnosis, and treatment
Hirokazu Takami1, Kaishi Satomi2, Anthony Pak Yin Liu3
1Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Abstract:
Non-germinomatous germ cell tumors (NGGCTs) are rare, histologically diverse malignancies that primarily affect children and adolescents. Unlike germinomas, NGGCTs are less responsive to chemotherapy and radiation, resulting in a less favorable prognosis and necessitating intensified multimodal therapy. This chapter provides a comprehensive overview of NGGCTs, including histological subtypes, clinical presentation, diagnostic strategies, and established as well as emerging treatment paradigms. We discuss current classification systems, the roles of tumor markers and neuroimaging, and challenges in histopathologic diagnosis. Treatment approaches vary globally but typically include intensive chemotherapy combined with craniospinal or whole-ventricular irradiation. Long-term outcomes remain suboptimal for high-risk subtypes, especially those with yolk sac tumor, choriocarcinoma or embryonal carcinoma components. Recent genomic and epigenomic studies have revealed recurrent alterations in the RTK/MAPK and PI3K/mTOR pathways, along with distinctive methylation signatures and copy number aberrations, offering insights into tumorigenesis and potential therapeutic targets. Ongoing trials continue to focus on refining risk stratification and minimizing treatment-related toxicities. These efforts, along with advances in molecular characterization, may ultimately improve survival and long-term quality of life in patients with CNS NGGCTs.
Insights
Non-germinomatous germ cell tumors (NGGCTs) are rare pediatric brain cancers. Improved molecular insights and targeted therapies are crucial for better outcomes in these challenging malignancies.
Area of Science:
- Neuro-oncology
- Pediatric Oncology
- Molecular Pathology
Background:
- Non-germinomatous germ cell tumors (NGGCTs) are rare, diverse pediatric brain malignancies.
- NGGCTs exhibit lower chemosensitivity and radioresistance compared to germinomas, necessitating aggressive multimodal treatment.
- Current treatment strategies often yield suboptimal long-term outcomes, particularly for high-risk subtypes.
Purpose of the Study:
- To provide a comprehensive overview of NGGCTs, encompassing histology, clinical presentation, diagnosis, and treatment.
- To review established and emerging therapeutic paradigms for central nervous system (CNS) NGGCTs.
- To highlight recent molecular findings and their implications for future therapeutic targets.
Main Methods:
- Review of histological subtypes, clinical presentation, and diagnostic modalities including tumor markers and neuroimaging.
- Discussion of global treatment approaches, including chemotherapy and radiotherapy regimens.
- Analysis of recent genomic and epigenomic studies identifying key molecular alterations.
Main Results:
- NGGCTs present diverse histological features and diagnostic challenges.
- Intensive chemotherapy combined with irradiation is a common treatment, but long-term outcomes are suboptimal for high-risk groups.
- Recurrent alterations in RTK/MAPK and PI3K/mTOR pathways, alongside methylation and copy number aberrations, offer potential therapeutic targets.
Conclusions:
- CNS NGGCTs require intensified multimodal therapy due to limited response to conventional treatments.
- Advances in molecular characterization are crucial for understanding NGGCT tumorigenesis and identifying novel therapeutic strategies.
- Ongoing research focuses on refining risk stratification and reducing treatment toxicity to improve patient survival and quality of life.
